scholarly journals Feasibility of Using Virtual Reality to Assess Nicotine Cue Reactivity During Treatment

2011 ◽  
Vol 22 (2) ◽  
pp. 159-165 ◽  
Author(s):  
Eili Kaganoff ◽  
Patrick S. Bordnick ◽  
Brian Lee Carter
Keyword(s):  
Smoking Cessation ◽  
Virtual Reality ◽  
Cue Reactivity ◽  
Treatment Decisions ◽  
Treatment Seeking ◽  
Cigarette Smokers ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment ◽  
Assessment Approach ◽  
Treatment Measures

Cue reactivity assessments have been widely used to assess craving and attention to cues among cigarette smokers. Cue reactivity has the potential to offer insights into treatment decisions; however, the use of cue reactivity in treatment studies has been limited. This study assessed the feasibility of using a virtual reality–based cue reactivity assessment approach (VR-NCRAS) during treatment. In a clinical smoking cessation treatment study, 46 treatment-seeking nicotine-dependent adult smokers were assessed for cue reactivity at baseline, Week 4, and Week 10 of treatment. Measures of cue reactivity included subjective craving and attention to cues after exposure to two neutral and two smoking cue environments. Overall, feasibility of using VR-NCRAS was demonstrated and these findings support the use of the cue reactivity assessment during treatment, which can inform treatment decisions.

scholarly journals Efficacy of a sleep health intervention to optimize standard smoking cessation treatment response: results from a pilot randomized controlled trial

2020 ◽  
Vol 15 (2) ◽  
pp. 113-117
Author(s):  
Freda Patterson ◽  
Michael A. Grandner ◽  
Susan K. Malone ◽  
Ryan T. Pohlig ◽  
Rebecca L. Ashare ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Treatment Response ◽  
Sex Education ◽  
Smoking Status ◽  
Controlled Trial ◽  
Treatment Seeking ◽  
Sleep Health ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment ◽  
End Of Treatment

AbstractBackgroundWe tested if an adjunctive sleep health (SH) intervention improved smoking cessation treatment response by increasing quit rates. We also examined if baseline sleep, and improvements in sleep in the first weeks of quitting, were associated with quitting at the end of treatment.MethodsTreatment-seeking smokers (N = 29) aged 21–65 years were randomized to a SH intervention (n = 16), or general health (GH) control (n = 13) condition. Participants received six counseling sessions across 15-weeks: SH received smoking cessation + SH counseling; GH received smoking cessation + GH counseling. Counseling began 4-weeks before the target quit date (TQD), and varenicline treatment began 1-week prior to TQD. Smoking status and SH were assessed at baseline (week 1), TQD (week 4), 3 weeks after cessation (week 7), week 12, and at the end of treatment (EOT; week 15).ResultsSH versus GH participants had higher Carbon Monoxide (CO) -verified, 7-day point prevalence abstinence at EOT (69% vs. 54%, respectively; adjusted odds ratio (aOR) = 2.10, 95% confidence interval (CI) = 0.40–10.69, P = 0.77). Higher baseline sleep efficiency (aOR = 1.42, 95% CI = 1.03–1.96, P = 0.03), predicted higher EOT cessation. Models were adjusted for age, sex, education, and baseline nicotine dependence.ConclusionsImproving SH in treatment-seeking smokers prior to cessation warrants further examination as a viable strategy to promote cessation.

scholarly journals Smoking Cessation Treatment and Outcomes in Medium to Heavy Cigarette Smokers being Treated for Cancer in Jordan

2013 ◽  
Vol 14 (11) ◽  
pp. 6875-6881 ◽  
Author(s):  
Feras Ibrahim Hawari ◽  
Nour Ali Obeidat ◽  
Hiba Salem Ayub ◽  
Sahar Sattam Dawahrah ◽  
Saif Feras Hawari
Keyword(s):  
Smoking Cessation ◽  
Cigarette Smokers ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment

scholarly journals Development of a Brief Motivational Intervention to Facilitate Engagement of Smoking Cessation Treatment Among Inpatient Depressed Smokers

2012 ◽  
Vol 7 (1) ◽  
pp. 4-11 ◽  
Author(s):  
David R. Strong ◽  
Lisa Uebelacker ◽  
Yael Chatav Schonbrun ◽  
Ayla Durst ◽  
Jennifer Saritelli ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Phase 1 ◽  
Psychiatric Inpatient ◽  
Depression Symptoms ◽  
High Risk Population ◽  
Motivational Intervention ◽  
Cigarette Smokers ◽  
Smoking Cessation Treatment ◽  
Brief Motivational Intervention ◽  
Cessation Treatment

Inpatient smokers with major depressive disorder (MDD) have high rates of relapse to smoking after hospital discharge. The risk of health consequences that may contribute to increased morbidity and mortality among this population underscores the need to develop a program for psychiatric inpatient cigarette smokers with MDD. Using a motivational interviewing (MI) intervention, we sought to facilitate engagement of smokers with elevated depression symptoms in an outpatient treatment with demonstrated efficacy for nicotine dependence. In Phase 1 of this program, we recruited 15 smokers with MDD who were receiving inpatient psychiatric services. This preliminary report focuses on the development of the intervention, and explores perceived barriers to quitting, methods of quitting, and interest in smoking cessation treatment following discharge from an inpatient stay. Understanding inpatient cigarette smokers’ interests in making changes in smoking, and in willingness to attempt cessation and engage in cessation treatment can inform efforts to curb smoking in this high-risk population.

scholarly journals Neural correlates of tobacco cue reactivity predict duration to lapse and continuous abstinence in smoking cessation treatment

2017 ◽  
Vol 23 (5) ◽  
pp. 1189-1199 ◽  
Author(s):  
Max M. Owens ◽  
James MacKillop ◽  
Joshua C. Gray ◽  
Steven R.H. Beach ◽  
Michael D. Stein ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Cue Reactivity ◽  
Neural Correlates ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment ◽  
Continuous Abstinence
Sign in / Sign up

Export Citation Format

Share Document